Iterum Therapeutics plc (ITRMF) Net income 2017–2025
Iterum Therapeutics plc (ITRMF) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$24.8MFY2025 · since FY2017: -$13.5M → -$24.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$24.8M | +35.4% |
| FY2024 | -$38.4M | +13.6% |
| FY2023 | -$44.4M | +51.5% |
| FY2022 | -$91.6M | -76.1% |
| FY2021 | -$52.0M | +49.6% |
| FY2020 | -$103.1M | -33.8% |
| FY2019 | -$77.1M | -162.0% |
| FY2018 | -$29.4M | -118.4% |
| FY2017 | -$13.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice